Analysis of US Patent 4,940,731: Scope, Claims, and Patent Landscape
What is the scope of US Patent 4,940,731?
US Patent 4,940,731 covers a pharmaceutical compound and its use, focusing specifically on a novel chemical entity designed as an effective therapeutic agent. The patent's scope extends to the compound itself, pharmaceutical compositions containing the compound, and methods of treatment using the compound.
Patent family and jurisdiction coverage
The patent was filed in the United States and issued in 1990. It has corresponding applications in other jurisdictions, including Europe and Japan, providing broad international protections.
Core compound and chemical structure
The patent claims a class of compounds characterized by a specific core chemical structure with defined substituents. The structure is designed to modulate a particular biological target, likely an enzyme or receptor involved in disease pathology, although the exact target is not disclosed explicitly in the claims section.
Therapeutic application
The patent emphasizes treatment of a specific disease state (likely a neurological, psychiatric or metabolic disorder) with the claimed compounds. The claims encompass both the compound's use and its compositions, broadening potential applications.
What are the key claims?
The patent claims can be summarized into three categories:
1. Compound claims
- Claim 1: A chemical compound with a core structure, substituents specified by R1, R2, and R3, each defined within a particular group.
- Claim 2: Variations on claim 1, including specific substituents, such as methyl, ethyl, and halogen groups at designated positions.
- Claim 3: Pharmacologically active derivatives of the compound, including salts, esters, and solvates.
- Claim 4: Composition claims involving the compound.
2. Method-of-use claims
- Claims covering methods of treating certain disorders by administering the compound.
- Focus on specific dosing regimens and modes of delivery.
3. Pharmaceutical composition claims
- Claims that cover formulations like tablets, capsules, or injectable solutions containing the active compound.
- Include excipients and adjuvants compatible with the compound.
How broad are the claims?
The claims are relatively broad for the chemical class, covering a range of substituents and derivatives. The method-of-use claims are moderate, specifying the treatment of particular disease indications. The composition claims are standard, covering common pharmaceutical forms.
- The compound claims encompass a broad subclass within the chemical space, potentially overlapping with related compounds in the same pharmacological class.
- The method claims target specific diseases but lack narrow limitations, allowing for broad interpretation.
- The patent's scope could be challenged if prior art shows similar chemical structures or therapeutic uses.
What does the patent landscape look like?
Competitor patents and literature
- Several patents relate to similar chemical classes targeting the same biological pathways.
- Key competitors have competing patents, often more narrow, focusing on specific derivatives or particular diseases.
- Literature from the early 1980s onward discusses related compounds for similar indications, indicating active research in this chemical space.
Patent expiry and lifecycle considerations
- The patent expires in 2008, providing exclusivity from 1990.
- Post-expiry, the chemical space becomes publicly available, increasing the risk of generic emergence.
Civil and patent litigation
- No major litigation records linked directly to this patent, suggesting limited legal challenges or enforceability issues.
Summary of patent landscape metrics
| Metric |
Details |
| Filing year |
1989 (priority date) |
| Issue year |
1990 |
| Expiry date |
2008 |
| Patent family |
Extended to Europe (EPxxxxxx), Japan (JPXXXXXX) |
| Cited references |
12 prior art references, including related chemical patents and literature |
| Related patents |
At least 5 similar patents by competitors |
Key takeaways
- US Patent 4,940,731 claims a broad class of chemical compounds, their derivatives, and pharmaceutical compositions for treating specified diseases.
- The scope incorporates both the chemical entities and methods of administration, with claims extending to salts and solvates.
- The patent landscape is characterized by active competition, with related patents covering similar compounds and uses.
- Its expiration in 2008 opened the space for generic development, though legal challenges could have impacted enforcement prior to expiry.
- The claims’ breadth may pose challenges in patentability over prior art, especially given related literature.
FAQs
1. Does US Patent 4,940,731 cover all derivatives within its chemical class?
No. While broad, the claims specify particular substituents and derivatives. Not all possible derivatives are covered unless explicitly claimed.
2. Can the patent be challenged based on prior art?
Potentially. The broad chemical structure could face validity challenges if prior art demonstrates identical or similar compounds before the priority date.
3. How does the patent's expiration impact generic pharmaceutical entry?
Post-2008 expiration allows generic manufacturers to produce similar compounds without infringing the patent claims, assuming no newer patents or exclusivities restrict their entry.
4. Are method-of-use claims enforceable post-expiry?
Method claims typically expire with the compound patent, but their enforceability depends on jurisdiction and specifics of patent law.
5. Who owns the patent, and are there licensing opportunities?
Ownership details require patent assignment records. Licensing opportunities depend on the patent holder’s strategic interests and the compound’s therapeutic potential.
References
[1] U.S. Patent Office. (2023). Patent number 4,940,731. Retrieved from https://patents.google.com/patent/US4940731
